XML 42 R3.htm IDEA: XBRL DOCUMENT v2.4.1.9
Condensed Consolidated Statements of Operations (Unaudited) (USD $)
 3 Months Ended
Mar. 31, 2015
Mar. 31, 2014
Revenues:    
Revenue under collaborative research and development arrangements $ 4,245,571us-gaap_LicensesRevenue $ 1,435,727us-gaap_LicensesRevenue
Revenue under collaborative research and development arrangements with affiliated entity 112,500ino_LicenseFeeAndMilestoneRevenueFromAffiliatedEntity 116,964ino_LicenseFeeAndMilestoneRevenueFromAffiliatedEntity
Grants and miscellaneous revenue 808,566us-gaap_RevenueFromGrants 804,952us-gaap_RevenueFromGrants
Total revenues 5,166,637us-gaap_Revenues 2,357,643us-gaap_Revenues
Operating expenses:    
Research and development 9,426,320us-gaap_ResearchAndDevelopmentExpense 8,225,480us-gaap_ResearchAndDevelopmentExpense
General and administrative 4,107,928us-gaap_GeneralAndAdministrativeExpense 4,132,218us-gaap_GeneralAndAdministrativeExpense
Total operating expenses 13,534,248us-gaap_OperatingExpenses 12,357,698us-gaap_OperatingExpenses
Loss from operations (8,367,611)us-gaap_OperatingIncomeLoss (10,000,055)us-gaap_OperatingIncomeLoss
Other income (expense):    
Interest and other income, net 138,276us-gaap_InterestAndOtherIncome 52,076us-gaap_InterestAndOtherIncome
Change in fair value of common stock warrants (1,227)ino_ChangeInFairValueOfCommonStockWarrants (505,926)ino_ChangeInFairValueOfCommonStockWarrants
Loss on investment in affiliated entity (2,352,309)ino_ChangeInValueOfInvestmentsInAffiliatedCompany (376,963)ino_ChangeInValueOfInvestmentsInAffiliatedCompany
Net loss (10,582,871)us-gaap_ProfitLoss (10,830,868)us-gaap_ProfitLoss
Net loss attributable to non-controlling interest 1,092us-gaap_NetIncomeLossAttributableToNoncontrollingInterest 9,408us-gaap_NetIncomeLossAttributableToNoncontrollingInterest
Net loss attributable to Inovio Pharmaceuticals, Inc. $ (10,581,779)us-gaap_NetIncomeLoss $ (10,821,460)us-gaap_NetIncomeLoss
Net loss per common share attributable to Inovio Pharmaceuticals, Inc. stockholders:    
Basic (in USD per share) $ (0.17)us-gaap_EarningsPerShareBasic $ (0.20)us-gaap_EarningsPerShareBasic
Diluted (in USD per share) $ (0.18)us-gaap_EarningsPerShareDiluted $ (0.20)us-gaap_EarningsPerShareDiluted
Weighted average number of common shares outstanding used in per share calculations:    
Basic (in shares) 60,741,082us-gaap_WeightedAverageNumberOfSharesOutstandingBasic 55,159,002us-gaap_WeightedAverageNumberOfSharesOutstandingBasic
Diluted (in shares) 60,913,423us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding 55,159,002us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding